ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY TREATMENT WITH HIGH-DOSE INTERLEUKIN-2

被引：0
|
作者：
THOMPSON, JA [1 ]
PEACE, DJ [1 ]
KLARNET, JP [1 ]
KERN, DE [1 ]
GREENBERG, PD [1 ]
CHEEVER, MA [1 ]
机构：
[1] UNIV WASHINGTON,SCH MED,DEPT MICROBIOL IMMUNOL,SEATTLE,WA 98195
来源：
JOURNAL OF IMMUNOLOGY | 1986年 / 137卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3675 / 3680
页数：6
相关论文
共 50 条
  • [1] The treatment of disseminated skin melanoma with high-dose recombinant interleukin-2 in combination with chemotherapy
    Streltsova, O.
    Baranau, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] EFFICACY OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND OF HIGH-DOSE INTERLEUKIN-2 (IL2) INVIVO IN THE THERAPY OF DISSEMINATED MURINE LEUKEMIA
    THOMPSON, JA
    PEACE, DJ
    GREENBERG, PD
    CHEEVER, MA
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 346 - 346
  • [3] MYOSITIS FOLLOWING TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 FOR MALIGNANCY
    FINGER, DR
    PLOTZ, PH
    HEYWOOD, G
    [J]. JOURNAL OF RHEUMATOLOGY, 1995, 22 (11) : 2188 - 2188
  • [4] COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2
    THIJS, LG
    HACK, CE
    VANSCHIJNDEL, RJMS
    NUIJENS, JH
    WOLBINK, GJ
    EERENBERGBELMER, AJM
    VANDERVALL, H
    WAGSTAFF, J
    [J]. LANCET, 1989, 2 (8659): : 395 - 395
  • [5] Managing toxicities of high-dose interleukin-2
    Schwartz, RN
    Stover, L
    Dutcher, J
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (11): : 11 - 20
  • [6] High-dose interleukin-2 is an intensive treatment regardless of the venue of administration
    Schwartzentruber, DJ
    [J]. CANCER JOURNAL, 2001, 7 (02): : 103 - 104
  • [7] High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
    Silk, Ann W.
    Kaufman, Howard L.
    Curti, Brendan
    Mehnert, Janice M.
    Margolin, Kim
    McDermott, David
    Clark, Joseph
    Newman, Jenna
    Bommareddy, Praveen K.
    Denzin, Lisa
    Najmi, Saltanat
    Haider, Azra
    Shih, Weichung
    Kane, Michael P.
    Zloza, Andrew
    [J]. FRONTIERS IN ONCOLOGY, 2020, 9
  • [8] Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide
    Soni, S
    Lee, DS
    DiVito, J
    Bui, AH
    DeRaffele, G
    Radel, E
    Kaufman, HL
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (06) : 488 - 491
  • [9] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
  • [10] CARDIOMYOPATHY ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY
    BECK, AC
    WARD, JH
    HAMMOND, EH
    WRAY, RB
    SAMLOWSKI, WE
    [J]. WESTERN JOURNAL OF MEDICINE, 1991, 155 (03): : 293 - 296
12345